Genital HPV lesions and molluscum contagiosum occurring in patients receiving anti-TNF-alpha therapy.
Antoniou
Christina
C
Kosmadaki
Maria G
MG
Stratigos
Alexandros J
AJ
Katsambas
Andreas D
AD
D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D015535:Arthritis, Psoriatic / Q000188:drug therapy; D000068800:Etanercept; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000009:adverse effects* / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D000069285:Infliximab; D008976:Molluscum Contagiosum / Q000139:chemically induced* / Q000276:immunology; D008977:Molluscum contagiosum virus / Q000187:drug effects*; D030361:Papillomavirus Infections / Q000188:drug therapy* / Q000473:pathology; D011565:Psoriasis / Q000188:drug therapy; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use; D012008:Recurrence; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
D000911:Antibodies, Monoclonal; D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab; D000068800:Etanercept